rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-10-13
|
pubmed:abstractText |
We investigated the clinical and pathological findings relevant to the efficacy of corticosteroid treatment in IgA nephropathy patients with 0.5 to 2.0 g/day of proteinuria at the initiation of corticosteroid treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1342-1751
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
243-9
|
pubmed:dateRevised |
2006-3-1
|
pubmed:meshHeading |
pubmed-meshheading:15480902-Adrenal Cortex Hormones,
pubmed-meshheading:15480902-Adult,
pubmed-meshheading:15480902-Anti-Inflammatory Agents,
pubmed-meshheading:15480902-Female,
pubmed-meshheading:15480902-Follow-Up Studies,
pubmed-meshheading:15480902-Glomerulonephritis, IGA,
pubmed-meshheading:15480902-Humans,
pubmed-meshheading:15480902-Kidney,
pubmed-meshheading:15480902-Kidney Function Tests,
pubmed-meshheading:15480902-Male,
pubmed-meshheading:15480902-Prednisolone,
pubmed-meshheading:15480902-Proteinuria,
pubmed-meshheading:15480902-Recurrence
|
pubmed:year |
2004
|
pubmed:articleTitle |
Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
|
pubmed:affiliation |
Fujinomiya City Hospital, 3-1 Nishiki-cho, Fujinomiya 418-0076, Japan. ctakayu@d1.dion.ne.jp.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|